For over 40 years, our team of 1,000+ experienced professionals have provided the full range of Contract Research Organization expertise necessary to conduct clinical research with a firm scientific basis that is fully compliant with national and international regulatory guidelines. With offices throughout the US, Europe, Canada, and India, Emmes supports the advancement of global public health and biopharmaceutical innovation through disciplined science, rigorous research, fact-based decision-making, and operational excellence.
Emmes possesses knowledge across a broad range of therapeutic areas, with specializations in Vaccines and Infectious Diseases, Ophthalmology, Immunology and Neuroscience. From comprehensive support of pandemic research to groundbreaking work in cell and gene therapy across the globe, Emmes has collaborated on clinical research across a wide array of disease states in over 75 nations.
As a strategic collaborator with applied talent in over 2,000 clinical trials and contributions to over 2,500 publications that advance the understanding of medicine and public health, Emmes is committed to expanding the services offered to best meet the changing needs of clients and studies. Ongoing investments in global clinical research capabilities, innovative data management platforms, biostatistics/bioinformatics expertise, and people have enabled Emmes to provide a multi-faceted approach to help you meet your research objectives.
Emmes is a diverse, inclusive, innovative CRO that values integrity, agility, passion for excellence, collaborative partnerships, and intellectual curiosity.
Emmes possesses knowledge across a broad range of therapeutic areas, with specializations in Vaccines and Infectious Diseases, Ophthalmology, Immunology and Neuroscience. From comprehensive support of pandemic research to groundbreaking work in cell and gene therapy across the globe, Emmes has collaborated on clinical research across a wide array of disease states in over 75 nations.
As a strategic collaborator with applied talent in over 2,000 clinical trials and contributions to over 2,500 publications that advance the understanding of medicine and public health, Emmes is committed to expanding the services offered to best meet the changing needs of clients and studies. Ongoing investments in global clinical research capabilities, innovative data management platforms, biostatistics/bioinformatics expertise, and people have enabled Emmes to provide a multi-faceted approach to help you meet your research objectives.
Emmes is a diverse, inclusive, innovative CRO that values integrity, agility, passion for excellence, collaborative partnerships, and intellectual curiosity.
Location: United States, Maryland, Rockville
Employees: 1001-5000
Founded date: 1977
Investors 1
| Date | Name | Website |
| - | Behrman Ca... | behrmancap... |
Mentions in press and media 15
| Date | Title | Description |
| 04.09.2024 | Emmes awarded multi-task, IDIQ contract with $50M ceiling, to support NIDA's clinical trials network | Emmes, part of Emmes Group, today announced they will provide a Clinical Coordinating Center for the NIH's National Institute on Drug Abuse Clinical Trials ROCKVILLE, Md., Sept. 4, 2024 /PRNewswire/ -- Emmes, part of Emmes Group, a leading ... |
| 25.04.2023 | Emmes Applauded by Frost & Sullivan for Streamlining Clinical Trials and for Its Competitive Strategies | Emmes collaborates with pharmaceutical companies as strategic partners, providing one-stop clinical trial services, reducing costs, and accelerating development. SAN ANTONIO, April 25, 2023 /PRNewswire/ -- Frost & Sullivan researched th... |
| 15.11.2021 | Emmes and MedGenome Launch Genomics Strategic Partnership Focused on Advancing Rare Disease Research | Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced a partnership with MedGenome aimed at accelerating breakthrough treatmen... |
| 21.09.2021 | Emmes Standardizes Veeva Development Cloud To Update Product Development | Global CRO Relies on Technology to Drive Scalability, Efficiency and Compatibility Emmes and Veeva Systems (VEEV) announced that Emmes is standardizing Veeva Development Cloud applications across all functional areas to enable greater speed... |
| 02.08.2021 | Emmes Announces New Role for the Blood and Marrow Transplant Clinical Trials Network | |
| 12.05.2021 | Emmes Announces Acquisition of UK-Based Orphan Reach USA - English USA - English | |
| 19.04.2021 | Rhonda Henry Named President of Emmes' BioPharma Group | ROCKVILLE, Md., April 19, 2021 /PRNewswire/ -- Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Rhonda Henry h... |
| 08.02.2021 | Emmes Employees Contribute to New England Journal of Medicine Report on Pregnant Women with Epilepsy | |
| 11.01.2021 | Paul VanVeldhuisen, Ph.D., Named President of Emmes' New Public Sector Group | |
| 30.12.2020 | Emmes Acquires Neox s.r.o., a Clinical Research Organization Headquartered in the Czech Republic USA - English France - Français España - español USA - English Deutschland - Deutsch |
Show more